by 11 percent from the previous year (after having cut it in half in 2009 to finance the Wyeth acquisition). Returning all of Pfizer���s cash flow to its investors certainly makes Mr. Reid���s vaguely stated commitment to spin off parts of the company...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to A Pfizer Break Up? That Would Be Something
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account